FindTrial
Sign In

The Efficacy and Safety of Feiyanqinghuafang on Severe Pneumonia

The Efficacy and Safety of Feiyanqinghuafang on Severe Pneumonia

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2200006509
Enrollment
Unknown
Registered
2022-08-19
Start date
2022-08-18
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

severe pneumonia

Interventions

two:Feiyanqinghuafang

Sponsors

Zhongshan Hospital, Fudan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: (1) conform to the diagnosis of severe pneumonia; (2) conform to the diagnosis of phlegm heat blocking lung syndrome for traditional Chinese medicines criteria; (3) Age 18-85 years old; (4) The patients participated and signed the informed consent form.

Exclusion criteria

Exclusion criteria: (1) Before the onset of the disease, there was no serious heart failure, serious liver and kidney failure; (2) Active malignant tumor or immune deficiency; (3) Drug abuse; (4) Pregnant women or lactation; (5) Incapacity; (6) The researcher believes that it is not suitable to be included in the study.

Design outcomes

Primary

MeasureTime frame
mortality;—

Countries

China

Contacts

Public ContactYuanlin Song
song.yuanlin@zs-hospital.sh.cn15021757762

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026